Drug or technology

Lidocaine Hydrochloride AND Epinephrine

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

APR 1, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Lidocaine Hydrochloride AND Epinephrine (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval for labeling change to a long-established local anesthetic combination; does not report clinical trial data or comparative efficacy.

Regulatory UpdateLidocaine Hydrochloride AND Epinephrine Hospira

Reported

Approval date2026-04-01

Product formulationEpinephrine 0.005 mg/mL + Lidocaine hydroch…

APR 1, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Lidocaine Hydrochloride AND Epinephrine (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval for labeling changes to an established local anesthetic combination; does not report clinical trial data or efficacy evidence.

Regulatory UpdateLidocaine Hydrochloride AND Epinephrine Hospira

Reported

Approval date2026-04-01

Epinephrine concentration0.01 mg/mL

Lidocaine hydrochloride concentra…1%